{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:12:25Z","timestamp":1778944345618,"version":"3.51.4"},"reference-count":28,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-14-1203","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T17:03:41Z","timestamp":1425315821000},"page":"1307-1314","source":"Crossref","is-referenced-by-count":27,"title":["Plasma Renin Activity Is a Strong and Independent Prognostic Indicator in Patients With Acute Decompensated Heart Failure Treated With Renin-Angiotensin System Inhibitors"],"prefix":"10.1253","volume":"79","author":[{"given":"Tomoya","family":"Ueda","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Kawakami","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Nishida","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Onoue","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunenari","family":"Soeda","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Okayama","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiji","family":"Takeda","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Watanabe","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kawata","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Uemura","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Regulatory Medicine for Blood Pressure, Nara Medical University"},{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pang PS, Komajda M, Gheorghiade M. The current and future management of acute heart failure syndromes. <i>Eur Heart J<\/i> 2010; 31: 784\u2013793.","DOI":"10.1093\/eurheartj\/ehq040"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bueno H, Ross JS, Wang Y, Chen J, Vidan MT, Normand SL, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993\u20132006. <i>JAMA<\/i> 2010; 303: 2141\u20132147.","DOI":"10.1001\/jama.2010.748"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, et al. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry). <i>Circ J<\/i> 2013; 77: 944\u2013951.","DOI":"10.1253\/circj.CJ-13-0187"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. <i>N Engl J Med<\/i> 1999; 341: 577\u2013585.","DOI":"10.1056\/NEJM199908193410806"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mann DL, Bristow MR. Mechanisms and models in heart failure: The biomechanical model and beyond. <i>Circulation<\/i> 2005; 111: 2837\u20132849.","DOI":"10.1161\/CIRCULATIONAHA.104.500546"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vergaro G, Emdin M, Iervasi A, Zyw L, Gabutti A, Poletti R, et al. Prognostic value of plasma renin activity in heart failure. <i>Am J Cardiol<\/i> 2011; 108: 246\u2013251.","DOI":"10.1016\/j.amjcard.2011.03.034"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. <i>Eur Heart J<\/i> 2004; 25: 292\u2013299.","DOI":"10.1016\/j.ehj.2003.10.030"},{"key":"8","unstructured":"8. Opie LH. Mechanisms of cardiac contraction and relaxation. <i>In<\/i>: Braunwald E, editor. Heart disease, 7th edn. Philadelphia: Saunders, 2004; 457 \u2013 489."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on AE Inhibitor Trials. <i>JAMA<\/i> 1995; 273: 1450\u20131456.","DOI":"10.1001\/jama.1995.03520420066040"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme. <i>Lancet<\/i> 2003; 362: 759\u2013766.","DOI":"10.1016\/S0140-6736(03)14282-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. <i>Lancet<\/i> 1999; 353: 9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. <i>N Engl J Med<\/i> 2001; 344: 1651\u20131658.","DOI":"10.1056\/NEJM200105313442201"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ueda T, Kawakami R, Horii M, Sugawara Y, Matsumoto T, Okada S, et al. High mean corpuscular volume is a new indicator of prognosis in acute decompensated heart failure. <i>Circ J<\/i> 2013; 77: 2766\u20132771.","DOI":"10.1253\/circj.CJ-13-0718"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. <i>J Am Coll Cardiol<\/i> 1993; 22: 6A\u201313A.","DOI":"10.1016\/0735-1097(93)90455-A"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Brunner HR, Sealey JE, Laragh JH. Renin as a risk factor in essential hypertension: More evidence. <i>Am J Med<\/i> 1973; 55: 295\u2013302.","DOI":"10.1016\/0002-9343(73)90131-9"},{"key":"16","unstructured":"16. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure: Relations to survival and the effects of therapy in V-HeFT II: The V-HeFT VA Cooperative Studies Group. <i>Circulation<\/i> 1993; 87: VI40\u2013VI48."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rouleau JL, Packer M, Moye L, de Champlain J, Bichet D, Klein M, et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captopril. <i>J Am Coll Cardiol<\/i> 1994; 24: 583\u2013591.","DOI":"10.1016\/0735-1097(94)90001-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. <i>N Engl J Med<\/i> 1984; 311: 819\u2013823.","DOI":"10.1056\/NEJM198409273111303"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Association (HFA) of the ESC. <i>Eur Heart J<\/i> 2012; 33: 1787\u20131847.","DOI":"10.1093\/eurheartj\/ehs104"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. <i>J Am Coll Cardiol<\/i> 2013; 62: e147\u2013e239, doi:10.1016\/j.jacc.2013.05.019.","DOI":"10.1016\/j.jacc.2013.05.019"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. JCS Joint Working Group. Guidelines for treatment of acute heart failure (JCS 2011): Digest version. <i>Circ J<\/i> 2013; 77: 2157\u20132201.","DOI":"10.1253\/circj.CJ-66-0068"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, et al. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. <i>Int J Cardiol<\/i> 2006; 106: 367\u2013372.","DOI":"10.1016\/j.ijcard.2005.02.016"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Schroten NF, Gaillard CA, van Veldhuisen DJ, Szymanski MK, Hillege HL, de Boer RA. New roles for renin and prorenin in heart failure and cardiorenal crosstalk. <i>Heart Fail Rev<\/i> 2012; 17: 191\u2013201.","DOI":"10.1007\/s10741-011-9262-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. <i>N Engl J Med<\/i> 1999; 341: 709\u2013717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. <i>N Engl J Med<\/i> 2003; 348: 1309\u20131321.","DOI":"10.1056\/NEJMoa030207"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. <i>N Engl J Med<\/i> 2011; 364: 11\u201321.","DOI":"10.1056\/NEJMoa1009492"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kinouchi K, Ichihara A, Sano M, Sun-Wada GH, Wada Y, Kurauchi-Mito A, et al. The (pro)renin receptor\/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. <i>Circ Res<\/i> 2010; 107: 30\u201334.","DOI":"10.1161\/CIRCRESAHA.110.224667"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ando T, Ichihara A. Novel approach to cardiovascular diseases: A promising probability of (pro)renin receptor [(P)RR]. <i>Curr Pharm Des<\/i> 2014; 20: 2371\u20132376.","DOI":"10.2174\/13816128113199990472"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/6\/79_CJ-14-1203\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T02:33:28Z","timestamp":1498185208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/6\/79_CJ-14-1203\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-14-1203","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}